Abstract

Significant successes in cancer treatment with the current generation of innovative therapies that target and boost the patients immune system have lead to an explosion of interest and activity in the field of immuno-oncology. CR-UK is in a unique position to discover and generate further advances in the field by utilizing both its extensive basic and clinical research network and the established drug discovery alliance capabilities in its Therapeutic Discovery Laboratories. This presentation will discuss how innovative discovery alliances in CR-UK are already driving this critical area forward.